Liver resection should be the primary therapeutic option for patients with early multinodular hepatocellular carcinoma (HCC) who are ineligible for transplant, a retrospective cohort study suggested.
In this retrospective cohort study, liver resection (LR) showed higher 1-, 3-, and 5-year survival rates than percutaneous radiofrequency ablation (PRFA) or transarterial chemoembolization (TACE).
Michael Hall, Christin Grundström, Afshan Begum, Mikael J. Lindberg, Uwe H. Sauer, Fredrik Almqvist, Jörgen Johansson, A. Elisabeth Sauer-Eriksson Proceedings of the National Academy of Sciences of ...
PrfA, the Ace in the Hole for L. monocytogenes Intracellular Survival In addition to the lysine substitution mutations within the putative PrfA cofactor-binding pocket, one additional mutation has ...
In Early Recurrent Liver Cancer, Surgery and Radiofrequency Ablation Spark Similar Survival Benefits
Radiofrequency ablation was statistically on par with surgery when it came to survival after an early recurrence of liver cancer, but surgery provided more benefit if the disease was a bit more ...
Intracellular pathogens are responsible for much of the world-wide morbidity and mortality due to infectious diseases. To colonize their hosts successfully, pathogens must sense their environment and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results